tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
RLAY is currently covered by 6 analysts with an average price target of $23.55. This is a potential upside of $9.64 (20.52%) from yesterday's end of day stock price of $19.54.
Relay Therapeutics 's activity chart (see below) currently has 123 price targets and 107 ratings on display. The stock rating distribution of RLAY is 82.35% BUY and 17.65% HOLD.
Analysts average stock forecasts to be materialized ratio is 41.38% with an average time for these price targets to be met of 309.65 days.
Highest price target for RLAY is $31, Lowest price target is $18, average price target is $23.55.
Most recent stock forecast was given by SALVEEN RICHTER from GOLDMAN SACHS on 21-Jul-2026. First documented stock forecast 10-Aug-2020.
Currently out of the existing stock ratings of RLAY, 14 are a BUY (82.35%), 3 are a HOLD (17.65%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Aug-2020
$31
$12.17 (64.63%)
$22
14 days ago
(21-Jul-2026)
2/5 (40%)
$11.7 (60.62%)
575
Buy Since 05-Apr-2023
$28
$9.17 (48.70%)
$11
27 days ago
(08-Jul-2026)
2/10 (20%)
$8.37 (42.64%)
164
Buy Since 05-Nov-2020
$28
$9.17 (48.70%)
$25
2 months 9 days ago
(26-May-2026)
15/26 (57.69%)
$13.83 (97.60%)
523
Buy Since 27-Feb-2026
$21
$2.17 (11.52%)
$17
3 months 7 days ago
(28-Apr-2026)
3/5 (60%)
$7.97 (61.17%)
85
Buy Since 28-Apr-2026
$18
$-0.83 (-4.41%)
$14
3 months 7 days ago
(28-Apr-2026)
2/9 (22.22%)
$4.97 (38.14%)
65
What is RLAY (Relay Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on RLAY (Relay Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on RLAY (Relay Therapeutics )?
Which analyst is the currently most bullish on RLAY (Relay Therapeutics )?
Which analyst is the currently most reserved on RLAY (Relay Therapeutics )?
